ConductScience.org, home

Paper1968762

Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.

Kuwazuru Y and 8 others. Br J Haematol, 1990. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. Papers, record 1968762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1968762

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.
PubMed
Journal
Br J Haematol
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
2.35
iCite
Revised in PubMed
2019-07-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuwazuru YY
2Yoshimura AA
3Hanada SS
4Ichikawa MM
5Saito TT
6Uozumi KK
7Utsunomiya AA
8Arima TT
9Akiyama SS

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blast CrisisMajor topic
Drug ResistanceMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Membrane GlycoproteinsMajor topic
Neoplasm ProteinsMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Adult
Antineoplastic Combined Chemotherapy Protocols
Female
Humans
Immunoblotting
Male
Middle Aged
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42064075TLR2 activation potentiates P-glycoprotein-mediated methotrexate efflux and enhances cytotoxicity of human NK cells against acute lymphoblastic leukemia.Front Immunol2026https://conductscience.org/library/papers/42064075PubMed
35057108BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.Pharmaceutics2022https://conductscience.org/library/papers/35057108PubMed
29861776Cytotoxic Activity of Extracts from Plants of Central Argentina on Sensitive and Multidrug-Resistant Leukemia Cells: Isolation of an Active Principle from Gaillardia megapotamica.Evid Based Complement Alternat Med2018https://conductscience.org/library/papers/29861776PubMed
28685691Metabolomics Applications in Precision Medicine: An Oncological Perspective.Curr Top Med Chem2017https://conductscience.org/library/papers/28685691PubMed
28487651Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative.Front Pharmacol2017https://conductscience.org/library/papers/28487651PubMed
28420426Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.J Exp Clin Cancer Res2017https://conductscience.org/library/papers/28420426PubMed
26770832Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.Leuk Res Treatment2015https://conductscience.org/library/papers/26770832PubMed
25821558HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells.Genes Cancer2015https://conductscience.org/library/papers/25821558PubMed
25239700Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines.BMC Complement Altern Med2014https://conductscience.org/library/papers/25239700PubMed
24070327Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Biosci Rep2013https://conductscience.org/library/papers/24070327PubMed
23259070The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.Leuk Res Treatment2012https://conductscience.org/library/papers/23259070PubMed
22866119Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells.Oncol Lett2011https://conductscience.org/library/papers/22866119PubMed
22098951Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells.Chin J Cancer2012https://conductscience.org/library/papers/22098951PubMed
20676217Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by H NMR spectroscopy.Metabolomics2010https://conductscience.org/library/papers/20676217PubMed
15239391Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.Int J Hematol2004https://conductscience.org/library/papers/15239391PubMed
12824882Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.Cancer Sci2003https://conductscience.org/library/papers/12824882PubMed
12671692Is there a cloud in the silver lining for imatinib?Br J Cancer2003https://conductscience.org/library/papers/12671692PubMed
12040447Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571.Leukemia2002https://conductscience.org/library/papers/12040447PubMed
7948302P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.Ann Hematol1994https://conductscience.org/library/papers/7948302PubMed
7923552P-glycoprotein, multidrug resistance and tumor progression.Cancer Metastasis Rev1994https://conductscience.org/library/papers/7923552PubMed

See all 24 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1968762

GET https://conductscience.org/api/papers/v1/1968762/cited_by?page=2